A broad-spectrum antibacterial drug from the group of macrolide-azalides, bacteriostatic. By binding to the 50S subunit of ribosomes, it inhibits peptide translocation at the translation stage, inhibits protein synthesis, slows the growth and reproduction of bacteria, has a bactericidal effect in high concentrations. Affects the extra-and intracellularly located pathogens.
Microorganisms can be initially resistant to the antibiotic or can become resistant to it.
Indications drug Azithromycin
Infectious and inflammatory diseases caused by microorganisms sensitive to Azab 250:
infections of the upper respiratory tract and upper respiratory tract: pharyngitis, tonsillitis, sinusitis, otitis media;
lower respiratory tract infections: acute bronchitis, exacerbation of chronic bronchitis, pneumonia, incl. caused by atypical pathogens;
infections of the skin and soft tissues: common acne of moderate severity, erysipelas, impetigo, secondarily infected dermatosis;
the initial stage of Lyme disease (borreliosis) – erythema migrans (erythema migrans);
urinary tract infections caused by Chlamydia trachomatis (urethritis, cervicitis).